SCHEMBL4862719

SCHEMBL4862719

OC=C1CC=[C]O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16791395 0.56
SCHEMBL10616330 0.47
SCHEMBL10036543 0.45
SCHEMBL5318324 0.45
SCHEMBL8351884 0.41
SCHEMBL329462 0.37
SCHEMBL6718535 0.37
SCHEMBL605705 0.34
SCHEMBL1178 0.34
SCHEMBL444487 0.34

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549647-B1 SUBSTITUTED C-IMIDAZO¬1,2-A|PYRIDIN-3-YL-METHYLAMINES GRUENENTHAL GMBH (DE) 2006-04-12 EP claimed
US-7345055-B2 Substituted C-imidazo [1,2-α] pyridin-3-yl-methylamines GRUENENTHAL GMBH (DE) 2008-03-18 US disclosed
US-7342025-B2 Substituted C-imidazo[1,2-a]pyridin-3-yl-methylamines GRUENENTHAL GMBH (DE) 2008-03-11 US disclosed
EP-1549647-B1 SUBSTITUTED C-IMIDAZO¬1,2-A|PYRIDIN-3-YL-METHYLAMINES GRUENENTHAL GMBH (DE) 2006-04-12 EP disclosed
EP-1549650-B1 SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES GRUENENTHAL GMBH (DE) 2006-03-22 EP disclosed
US-20050239823-A1 Substituted C-imidazo[1,2-a]pyridin-3yl-methylamines GRUENENTHAL GMBH (DE) 2005-10-27 US disclosed
US-20050239822-A1 Substituted C-imiadazol[1,2-a] pyridin-3-yl-methylamines GRUENENTHAL GMBH (DE) 2005-10-27 US disclosed
EP-1549650-A1 SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES Grünenthal GmbH (DE) 2005-07-06 EP disclosed
EP-1549647-A1 SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES Grünenthal GmbH (DE) 2005-07-06 EP disclosed
US-20040142961-A1 Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations GRUENENTHAL GMBH (DE) 2004-07-22 US disclosed
US-20040122044-A1 Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulations GRUENENTHAL GMBH (DE) 2004-06-24 US disclosed
WO-2004035578-A1 SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES Grünenthal GmbH (DE) 2004-04-29 WO disclosed
WO-2004033453-A1 SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES Grünenthal GmbH (DE) 2004-04-22 WO disclosed
US-6703404-B2 NITRIC OXIDE SYNTHASE INHIBITORS GRUENENTHAL GMBH (DE) 2004-03-09 US disclosed
EP-1372647-A2 USE OF SUBSTITUTED IMIDAZO 1,2-A]-PYRIDINE COMPOUNDS AS MEDICAMENTS Grünenthal GmbH (DE) 2004-01-02 EP disclosed
EP-1372644-A2 USE OF SUBSTITUTED IMIDAZO 1,2-A]-PYRIDINE-3-YL-AMIDE AND IMIDAZO 1,2-A]-PYRIDINE-3-YL-AMINE COMPOUNDS AS MEDICAMENTS Grünenthal GmbH (DE) 2004-01-02 EP disclosed
EP-1218378-B1 TERT.-BUTYL-(7-METHYL-IMIDAZO[1,2-A]PYRIDINE-3-YL)-AMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2003-04-23 EP disclosed
US-20030022914-A1 Tert.-butyl-(7-menthyl-imidazol [1,2-A] pyridin-3-yl)-amine derivatives GRUENENTHAL GMBH . 2003-01-30 US disclosed
WO-2002080911-A2 USE OF SUBSTITUTED IMIDAZO[1,2-A]-PYRIDINE-3-YL-AMIDE AND IMIDAZO[1,2-A]-PYRIDINE-3-YL-AMINE COMPOUNDS AS MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Grünenthal GmbH (DE) 2002-10-17 WO disclosed
WO-2002080914-A2 USE OF SUBSTITUTED IMIDAZO[1,2-A]-PYRIDINE COMPOUNDS AS MEDICAMENTS Grünenthal GmbH (DE) 2002-10-17 WO disclosed